36.75INR
44.07 MINR
588.34 MINR
About SHUKRA PHARMACEUTICALS LIMITED
Sector
Headquarters
Ahmedabad
Employees (FY)
182
Website
Founded
1993
ISIN
INE551C01028
FIGI
BBG000DM6JG1
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SHUKRAPHAR is 325.85 INR — it has increased by 1.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SHUKRA PHARMACEUTICALS LIMITED stocks are traded under the ticker SHUKRAPHAR.
Yes, you can track SHUKRA PHARMACEUTICALS LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, SHUKRAPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHUKRA PHARMACEUTICALS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 182.00 employees. See our rating of the largest employees — is SHUKRA PHARMACEUTICALS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHUKRA PHARMACEUTICALS LIMITED EBITDA is 186.21 M INR, and current EBITDA margin is 10.98%. See more stats in SHUKRA PHARMACEUTICALS LIMITED financial statements.